156 related articles for article (PubMed ID: 25661990)
1. Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence.
Roten A; Baker NL; Gray KM
Addict Behav; 2015 Jun; 45():119-23. PubMed ID: 25661990
[TBL] [Abstract][Full Text] [Related]
2. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation.
Squeglia LM; Baker NL; McClure EA; Tomko RL; Adisetiyo V; Gray KM
Addict Behav; 2016 Dec; 63():172-7. PubMed ID: 27521979
[TBL] [Abstract][Full Text] [Related]
3. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine.
Tomko RL; Gilmore AK; Gray KM
Addict Behav; 2018 Oct; 85():26-30. PubMed ID: 29803870
[TBL] [Abstract][Full Text] [Related]
4. Working memory impairment in cannabis- and opioid-dependent adolescents.
Vo HT; Schacht R; Mintzer M; Fishman M
Subst Abus; 2014; 35(4):387-90. PubMed ID: 25148203
[TBL] [Abstract][Full Text] [Related]
5. Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects.
Mahmood OM; Jacobus J; Bava S; Scarlett A; Tapert SF
J Stud Alcohol Drugs; 2010 Nov; 71(6):885-94. PubMed ID: 20946746
[TBL] [Abstract][Full Text] [Related]
6. A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.
Gray KM; Sonne SC; McClure EA; Ghitza UE; Matthews AG; McRae-Clark AL; Carroll KM; Potter JS; Wiest K; Mooney LJ; Hasson A; Walsh SL; Lofwall MR; Babalonis S; Lindblad RW; Sparenborg S; Wahle A; King JS; Baker NL; Tomko RL; Haynes LF; Vandrey RG; Levin FR
Drug Alcohol Depend; 2017 Aug; 177():249-257. PubMed ID: 28623823
[TBL] [Abstract][Full Text] [Related]
7. Cognitive changes after surgery vs stenting for carotid artery stenosis.
Lal BK; Younes M; Cruz G; Kapadia I; Jamil Z; Pappas PJ
J Vasc Surg; 2011 Sep; 54(3):691-8. PubMed ID: 21700413
[TBL] [Abstract][Full Text] [Related]
8. Dose-related neurocognitive effects of marijuana use.
Bolla KI; Brown K; Eldreth D; Tate K; Cadet JL
Neurology; 2002 Nov; 59(9):1337-43. PubMed ID: 12427880
[TBL] [Abstract][Full Text] [Related]
9. Cannabis use and premorbid functioning as predictors of poorer neurocognition in schizophrenia spectrum disorder.
Ringen PA; Melle I; Berg AO; Agartz I; Spigset O; Simonsen C; Sundet K; Andreassen OA
Schizophr Res; 2013 Jan; 143(1):84-9. PubMed ID: 23178107
[TBL] [Abstract][Full Text] [Related]
10. A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents.
Gray KM; Carpenter MJ; Baker NL; DeSantis SM; Kryway E; Hartwell KJ; McRae-Clark AL; Brady KT
Am J Psychiatry; 2012 Aug; 169(8):805-12. PubMed ID: 22706327
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence.
Medina KL; Hanson KL; Schweinsburg AD; Cohen-Zion M; Nagel BJ; Tapert SF
J Int Neuropsychol Soc; 2007 Sep; 13(5):807-20. PubMed ID: 17697412
[TBL] [Abstract][Full Text] [Related]
12. Specificity of verbal learning impairment and recovery in a marijuana-dependent male: the effects of sustained marijuana abstinence.
Vadhan NP; van Gorp WG; Levin FR
Cogn Neuropsychiatry; 2011 Mar; 16(2):158-73. PubMed ID: 21253958
[TBL] [Abstract][Full Text] [Related]
13. The residual cognitive effects of heavy marijuana use in college students.
Pope HG; Yurgelun-Todd D
JAMA; 1996 Feb; 275(7):521-7. PubMed ID: 8606472
[TBL] [Abstract][Full Text] [Related]
14. Marijuana craving trajectories in an adolescent marijuana cessation pharmacotherapy trial.
Roten AT; Baker NL; Gray KM
Addict Behav; 2013 Mar; 38(3):1788-91. PubMed ID: 23261493
[TBL] [Abstract][Full Text] [Related]
15. Heavy alcohol use, marijuana use, and concomitant use by adolescents are associated with unique and shared cognitive decrements.
Winward JL; Hanson KL; Tapert SF; Brown SA
J Int Neuropsychol Soc; 2014 Sep; 20(8):784-95. PubMed ID: 25241623
[TBL] [Abstract][Full Text] [Related]
16. Objective and subjective memory ratings in cannabis-dependent adolescents.
McClure EA; Lydiard JB; Goddard SD; Gray KM
Am J Addict; 2015 Jan; 24(1):47-52. PubMed ID: 25823635
[TBL] [Abstract][Full Text] [Related]
17. Identifying cognitive problems in children and adolescents with depression using computerized neuropsychological testing.
Brooks BL; Iverson GL; Sherman EM; Roberge MC
Appl Neuropsychol; 2010 Jan; 17(1):37-43. PubMed ID: 20146120
[TBL] [Abstract][Full Text] [Related]
18. Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings.
Meijer JH; Dekker N; Koeter MW; Quee PJ; van Beveren NJ; Meijer CJ;
Psychol Med; 2012 Apr; 42(4):705-16. PubMed ID: 21899795
[TBL] [Abstract][Full Text] [Related]
19. Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder.
Bentzley JP; Tomko RL; Gray KM
J Subst Abuse Treat; 2016 Apr; 63():72-7. PubMed ID: 26827257
[TBL] [Abstract][Full Text] [Related]
20. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
